Alaunos Therapeutics, Inc. Earnings Per Share (Basic)
Alaunos Therapeutics, Inc. (TCRT) reported Earnings Per Share (Basic) of -$0.41 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-14
- Alaunos Therapeutics, Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$0.41.
- Alaunos Therapeutics, Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$0.59.
- Alaunos Therapeutics, Inc. earnings per share, basic for the quarter ending 2025-12-31 was -$0.40.
- Alaunos Therapeutics, Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$0.55.
- Alaunos Therapeutics, Inc. earnings per share, basic for fiscal 2025 was -$2.20.
- Alaunos Therapeutics, Inc. earnings per share, basic for fiscal 2024 was -$2.92.
- Alaunos Therapeutics, Inc. earnings per share, basic for fiscal 2023 was -$21.97.
- Alaunos Therapeutics, Inc. earnings per share, basic for fiscal 2022 was -$2.61.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.41 10-Q · filed 2026-08-14 | -$0.85 10-Q · filed 2026-08-14 | -$1.38 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$1.93 derived: net income ÷ weighted average shares · filed 2026-08-14 | ||||
| 2026-03-31 | -$0.59 10-Q · filed 2026-05-15 | -$0.98 derived: net income ÷ weighted average shares · filed 2026-05-15 | -$1.53 derived: net income ÷ weighted average shares · filed 2026-05-15 | -$2.14 derived: net income ÷ weighted average shares · filed 2026-08-14 | ||||
| 2025-12-31 | -$0.40 derived: net income ÷ weighted average shares · filed 2026-03-31 | -$0.95 derived: net income ÷ weighted average shares · filed 2026-03-31 | -$1.55 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$2.20 10-K · filed 2026-03-31 | ||||
| 2025-09-30 | -$0.55 10-Q · filed 2025-11-14 | -$1.17 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$1.84 10-Q · filed 2025-11-14 | -$2.31 derived: net income ÷ weighted average shares · filed 2026-08-14 | ||||
| 2025-06-30 | -$0.63 10-Q · filed 2026-08-14 | -$1.30 10-Q · filed 2026-08-14 | -$1.77 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$2.47 derived: net income ÷ weighted average shares · filed 2026-08-14 | ||||
| 2025-03-31 | -$0.67 10-Q · filed 2026-05-15 | -$1.13 derived: net income ÷ weighted average shares · filed 2026-05-15 | -$1.84 derived: net income ÷ weighted average shares · filed 2026-05-15 | |||||
| 2024-12-31 | -$0.46 derived: net income ÷ weighted average shares · filed 2026-03-31 | -$1.17 derived: net income ÷ weighted average shares · filed 2026-03-31 | -$2.92 10-K · filed 2026-03-31 | |||||
| 2024-09-30 | -$0.70 10-Q · filed 2025-11-14 | -$2.46 10-Q · filed 2025-11-14 | ||||||
| 2024-06-30 | -$0.71 10-Q · filed 2025-08-14 | -$1.75 10-Q · filed 2025-08-14 | ||||||
| 2024-03-31 | -$1.05 10-Q · filed 2025-05-15 | -$0.11 10-Q · filed 2024-05-15 | ||||||
| 2023-12-31 | -$21.97 10-K · filed 2025-03-31 | -$2.20 10-K · filed 2024-04-01 | ||||||
| 2023-09-30 | -$5.30 10-Q · filed 2024-11-14 | -$0.04 10-Q · filed 2023-11-14 | -$17.07 10-Q · filed 2024-11-14 | -$0.11 10-Q · filed 2023-11-14 | ||||
| 2023-06-30 | -$5.49 10-Q · filed 2024-08-14 | -$0.04 10-Q · filed 2023-08-14 | -$11.78 10-Q · filed 2024-08-14 | -$0.08 10-Q · filed 2023-08-14 | ||||
| 2023-03-31 | -$0.63 10-Q · filed 2024-05-15 | -$0.04 10-Q · filed 2023-05-10 | ||||||
| 2022-12-31 | -$2.61 10-K · filed 2024-04-01 | -$0.17 10-K · filed 2023-03-07 | ||||||
| 2022-09-30 | -$0.04 10-Q · filed 2023-11-14 | -$0.13 10-Q · filed 2023-11-14 | ||||||
| 2022-06-30 | -$0.05 10-Q · filed 2023-08-14 | -$0.09 10-Q · filed 2023-08-14 | ||||||
| 2022-03-31 | -$0.05 10-Q · filed 2023-05-10 | |||||||
| 2021-12-31 | -$0.37 10-K · filed 2023-03-07 | |||||||
| 2021-09-30 | -$0.11 10-Q · filed 2022-11-14 | -$0.31 10-Q · filed 2022-11-14 | ||||||
| 2021-06-30 | -$0.11 10-Q · filed 2022-08-15 | -$0.21 10-Q · filed 2022-08-15 | ||||||
| 2020-12-31 | -$0.11 10-K · filed 2021-03-01 | -$0.38 10-K · filed 2021-03-01 | ||||||
| 2020-09-30 | -$0.10 10-K · filed 2021-03-01 | |||||||
| 2020-06-30 | -$0.09 10-K · filed 2021-03-01 | |||||||
| 2020-03-31 | -$0.09 10-K · filed 2021-03-01 | |||||||
| 2019-12-31 | -$0.09 10-K · filed 2021-03-01 | -$0.70 10-K · filed 2021-03-01 | ||||||
| 2019-09-30 | -$0.43 10-K · filed 2021-03-01 | |||||||
| 2019-06-30 | -$0.09 10-K · filed 2021-03-01 | |||||||
| 2019-03-31 | -$0.08 10-K · filed 2021-03-01 | |||||||
| 2018-12-31 | $1.29 10-K · filed 2020-03-02 | $0.96 10-K · filed 2021-03-01 | ||||||
| 2018-09-30 | -$0.13 10-K · filed 2020-03-02 | |||||||
| 2018-06-30 | -$0.12 10-K · filed 2020-03-02 | |||||||
| 2018-03-31 | -$0.15 10-K · filed 2020-03-02 | |||||||
| 2017-12-31 | -$0.53 10-K · filed 2020-03-02 | |||||||
| 2016-12-31 | -$1.32 10-K · filed 2019-03-05 | |||||||
| 2012-09-30 | -$0.23 10-Q · filed 2012-11-08 | -$0.85 10-Q · filed 2012-11-08 | ||||||
| 2012-06-30 | -$0.30 10-Q/A · filed 2012-08-28 | -$0.62 10-Q/A · filed 2012-08-28 | ||||||
| 2011-09-30 | -$0.01 10-Q · filed 2012-11-08 | -$0.77 10-Q · filed 2012-11-08 | ||||||
| 2011-06-30 | -$0.16 10-Q/A · filed 2012-08-28 | -$0.78 10-Q/A · filed 2012-08-28 | ||||||
| 2010-09-30 | -$0.26 10-Q · filed 2011-11-03 | -$0.48 10-Q · filed 2011-11-03 | ||||||
| 2010-06-30 | $0.21 10-Q/A · filed 2011-08-09 | -$0.21 10-Q/A · filed 2011-08-09 | ||||||
| 2009-09-30 | -$0.13 10-Q · filed 2011-08-01 | -$0.40 10-Q · filed 2011-08-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |